Chemotherapy for Leukemia by Takanori Ueda, Hardcover, 9789811033308 | Buy online at The Nile
Departments
 Free Returns*

Chemotherapy for Leukemia

Novel Drugs and Treatment

Author: Takanori Ueda  

Hardcover

This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years.

Read more
$529.79
Or pay later with
Check delivery options
Hardcover

PRODUCT INFORMATION

Summary

This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years.

Read more

Description

This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has been made possible with the development of molecular targeted agents such as bcr-abl tyrosine kinase inhibitors and all-trans retinoic acid. The antibody for the unique target of chemokine receptor 4 for adult T-cell leukemia/lymphoma, or FLT3 inhibitors (signaling inhibitors) has been applied to other leukemias. Also, chemotherapeutic agents including antimetabolite analogues such as clofarabine, and azacitidine (an epigenetic regulator) have undergone progressive development. Meanwhile, the novel concept of therapy targeting leukemic stem cells has been developed. The contributors discuss prospective results of basic and preclinical studies and clinical possibilities based on the effects for leukemic stem cells.

This work facilitates a comprehensive understanding of modern treatment methodology for leukemia. The volume therefore will greatly benefit not only hematologists but also oncologists, all physicians who specialize in blood cancer, and pharmacologists who are involved in the development of therapeutic agents for leukemia.

Read more

About the Author

Takanori Ueda

Vice-President, University of Fukui Faculty of Medical Sciences,

3-9-1 Bunkyo, Fukui 910-8507, Japan

Read more

Product Details

Publisher
Springer Verlag, Singapore
Published
26th April 2017
Edition
1st
Pages
361
ISBN
9789811033308

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.

$529.79
Or pay later with
Check delivery options